Does TADALAFIL Cause Fluid retention? 775 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 775 reports of Fluid retention have been filed in association with TADALAFIL (Esokalli Testosterone Booster Oral Dissolving Film). This represents 2.5% of all adverse event reports for TADALAFIL.
775
Reports of Fluid retention with TADALAFIL
2.5%
of all TADALAFIL reports
58
Deaths
527
Hospitalizations
How Dangerous Is Fluid retention From TADALAFIL?
Of the 775 reports, 58 (7.5%) resulted in death, 527 (68.0%) required hospitalization, and 20 (2.6%) were considered life-threatening.
Is Fluid retention Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TADALAFIL. However, 775 reports have been filed with the FAERS database.
What Other Side Effects Does TADALAFIL Cause?
Headache (3,196)
Drug ineffective (2,943)
Dyspnoea (2,881)
Death (1,917)
Diarrhoea (1,667)
Dizziness (1,374)
Nausea (1,368)
Asthenia (1,230)
Fatigue (1,135)
Hypertension (1,044)
What Other Drugs Cause Fluid retention?
AMBRISENTAN (3,927)
TREPROSTINIL (3,804)
MACITENTAN (2,861)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (2,233)
SACUBITRIL\VALSARTAN (2,187)
ADALIMUMAB (1,193)
SELEXIPAG (1,044)
FUROSEMIDE (1,020)
LENALIDOMIDE (1,007)
EPOPROSTENOL (929)
Which TADALAFIL Alternatives Have Lower Fluid retention Risk?
TADALAFIL vs TAFAMIDIS
TADALAFIL vs TAFAMIDIS MEGLUMINE
TADALAFIL vs TAFASITAMAB
TADALAFIL vs TAFASITAMAB-CXIX
TADALAFIL vs TAFINLAR